Overview Financials News + Filings Key Docs Charts Transactions Holdings Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Appointed director
|
|
Allergan plc (AGN)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 05/12/2020 |
4
| Basgoz Nesli (Director) has filed a Form 4 on Allergan plc|
Txns:
| Disposed/sold 6,889 shares
@ $0
Disposed/sold 2,790 options
@ $90.22, valued at
$251.7k
Disposed/sold 3,691 options
@ $73.14, valued at
$270k
Disposed/sold 2,619 options
@ $70.79, valued at
$185.4k
|
|
| 05/12/2020 |
4
| Boccuzi Joseph H (Director) has filed a Form 4 on Allergan plc|
Txns:
| Disposed/sold 3,605 shares
@ $0 |
|
| 05/11/2020 |
4
| HUGIN ROBERT J (Director) has filed a Form 4 on Allergan plc|
Txns:
| Disposed/sold 4,294 shares
@ $0 |
|
| 05/11/2020 |
4
| BODINE CHRIS W (Director) has filed a Form 4 on Allergan plc|
Txns:
| Disposed/sold 18,615 shares
@ $0 |
|
| 05/11/2020 |
4
| DArecca James (SVP Chief Accounting Officer) has filed a Form 4 on Allergan plc|
Txns:
| Disposed/sold 3,511 shares
@ $0
Disposed/sold 6,324 restricted stock units
@ $0
Disposed/sold 1,169 options
@ $296.14, valued at
$346.2k
Disposed/sold 4,957 options
@ $224, valued at
$1.1M
Disposed/sold 3,534 rights
@ $0 |
|
| 05/11/2020 |
4
| Brown Adriane M (Director) has filed a Form 4 on Allergan plc|
Txns:
| Disposed/sold 2,916 shares
@ $0 |
|
| 05/11/2020 |
4
| Bailey A Robert D (EVP Chief Legal Off & Corp Sec) has filed a Form 4 on Allergan plc|
Txns:
| Disposed/sold 17,629 shares
@ $0
Disposed/sold 16,800 restricted stock units
@ $0
Disposed/sold 16,524 options
@ $224, valued at
$3.7M
Disposed/sold 3,852 options
@ $103.79, valued at
$399.8k
Disposed/sold 509 options
@ $196.16, valued at
$99.8k
Disposed/sold 9,750 options
@ $103.79, valued at
$1M
Disposed/sold 12,304 options
@ $196.16, valued at
$2.4M
Disposed/sold 17,670 rights
@ $0 |
|
| 05/11/2020 |
4
| FREYMAN THOMAS C (Director) has filed a Form 4 on Allergan plc|
Txns:
| Disposed/sold 2,983 shares
@ $0 |
|
| 05/11/2020 |
4
| WALSH MATTHEW M (EVP, CFO) has filed a Form 4 on Allergan plc|
Txns:
| Disposed/sold 12,039 shares
@ $0
Disposed/sold 27,618 restricted stock units
@ $0
Disposed/sold 28,021 rights
@ $0 |
|
| 05/11/2020 |
4
| DAVIDSON CAROL ANTHONY (Director) has filed a Form 4 on Allergan plc|
Txns:
| Disposed/sold 2,105 shares
@ $0 |
|
| 05/11/2020 |
4
| Swanton Wayne R (EVP, Global Operations) has filed a Form 4 on Allergan plc|
Txns:
| Disposed/sold 8,915 shares
@ $0
Disposed/sold 12,050 restricted stock units
@ $0
Disposed/sold 5,508 options
@ $224, valued at
$1.2M
Disposed/sold 1,369 options
@ $307.51, valued at
$421k
Disposed/sold 12,129 rights
@ $0 |
|
| 05/11/2020 |
4
| Nicholson C. David (EVP Chief R&D Officer) has filed a Form 4 on Allergan plc|
Txns:
| Disposed/sold 9,999 shares
@ $0
Disposed/sold 25,201 restricted stock units
@ $0
Disposed/sold 17,006 options
@ $215.77, valued at
$3.7M
Disposed/sold 26,506 rights
@ $0 |
|
| 05/11/2020 |
4
| Greenberg Michael Eldon (Director) has filed a Form 4 on Allergan plc|
Txns:
| Disposed/sold 1,693 shares
@ $0 |
|
| 05/11/2020 |
4
| Meury William (EVP & Chief Commercial Officer) has filed a Form 4 on Allergan plc|
Txns:
| Disposed/sold 7,434 shares
@ $0
Disposed/sold 25,201 restricted stock units
@ $0
Disposed/sold 19,278 options
@ $224, valued at
$4.3M
Disposed/sold 1 options
@ $63.51, valued at
$63.5
Disposed/sold 1,387 options
@ $72.07, valued at
$100k
Disposed/sold 1,246 options
@ $80.2, valued at
$99.9k
Disposed/sold 509 options
@ $196.16, valued at
$99.8k
Disposed/sold 16,081 options
@ $63.51, valued at
$1M
Disposed/sold 10,089 options
@ $72.07, valued at
$727.1k
Disposed/sold 21,621 options
@ $80.2, valued at
$1.7M
Disposed/sold 12,304 options
@ $196.16, valued at
$2.4M
|
|
| 05/11/2020 |
4
| McDonnell Peter J (Director) has filed a Form 4 on Allergan plc|
Txns:
| Disposed/sold 6,352 shares
@ $0 |
|
| 05/11/2020 |
4
| SAUNDERS BRENT L (Chairman, President and CEO) has filed a Form 4 on Allergan plc|
Txns:
| Disposed/sold 149,384 shares
@ $0
Disposed/sold 79,805 restricted stock units
@ $0
Disposed/sold 104,651 options
@ $224, valued at
$23.4M
Disposed/sold 3,291 options
@ $91.13, valued at
$299.9k
Disposed/sold 1,018 options
@ $196.16, valued at
$199.7k
Disposed/sold 9,446 options
@ $70.79, valued at
$668.7k
Disposed/sold 3,691 options
@ $73.14, valued at
$270k
Disposed/sold 2,790 options
@ $90.22, valued at
$251.7k
Disposed/sold 219,667 options
@ $91.13, valued at
$20M
Disposed/sold 62,547 options
@ $196.16, valued at
$12.3M
Disposed/sold 1 options
@ $196.16, valued at
$196.2 |
|
| 05/11/2020 |
4
| COUGHLIN CHRISTOPHER J (Director) has filed a Form 4 on Allergan plc|
Txns:
| Disposed/sold 471 shares
@ $0
Disposed/sold 9,538 shares
@ $0
Disposed/sold 16,532 shares
@ $0
Disposed/sold 2,790 options
@ $90.22, valued at
$251.7k
Disposed/sold 3,691 options
@ $73.14, valued at
$270k
Disposed/sold 9,446 options
@ $70.79, valued at
$668.7k
|
|
| 05/04/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/04/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/04/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/04/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/04/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/04/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/04/2020 |
4
| Boccuzi Joseph H (Director) has filed a Form 4 on Allergan plc|
Txns:
| Paid exercise price by delivering 991 shares
@ $189.74, valued at
$188k
|
|
| 05/04/2020 |
4
| BODINE CHRIS W (Director) has filed a Form 4 on Allergan plc|
Txns:
| Paid exercise price by delivering 991 shares
@ $189.74, valued at
$188k
|
|
| 05/04/2020 |
4
| HUGIN ROBERT J (Director) has filed a Form 4 on Allergan plc|
Txns:
| Paid exercise price by delivering 2,064 shares
@ $189.74, valued at
$391.6k
|
|
| 05/04/2020 |
4
| McDonnell Peter J (Director) has filed a Form 4 on Allergan plc|
Txns:
| Paid exercise price by delivering 991 shares
@ $189.74, valued at
$188k
|
|
| 04/07/2020 |
4
| Nicholson C. David (EVP Chief R&D Officer) has filed a Form 4 on Allergan plc|
Txns:
| Granted 21,667 shares
@ $193.84, valued at
$4.2M
|
|
| 04/07/2020 |
4
| Meury William (EVP & Chief Commercial Officer) has filed a Form 4 on Allergan plc|
Txns:
| Paid exercise price by delivering 855 shares
@ $175.71, valued at
$150.2k
|
|
| 04/07/2020 |
4
| Bailey A Robert D (EVP Chief Legal Off & Corp Sec) has filed a Form 4 on Allergan plc|
Txns:
| Paid exercise price by delivering 581 shares
@ $175.71, valued at
$102.1k
|
|
| 03/10/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/10/2020 |
4
| DArecca James (SVP Chief Accounting Officer) has filed a Form 4 on Allergan plc|
Txns:
| Paid exercise price by delivering 718 shares
@ $191.95, valued at
$137.8k
|
|
| 03/04/2020 |
4
| Nicholson C. David (EVP Chief R&D Officer) has filed a Form 4 on Allergan plc|
Txns:
| Granted 21,667 shares
@ $193.84, valued at
$4.2M
|
|
| 03/04/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|
|
|